Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors.
about
Molecular mechanisms underlying occult hepatitis B virus infection.Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in EuropeRoutine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2.Clinical implications of hepatitis B virus mutations: recent advances.Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infectionApplication of a newly developed high-sensitivity HBsAg chemiluminescent enzyme immunoassay for hepatitis B patients with HBsAg seroclearance.Novel monitoring of hepatitis B reactivation based on ultra-high sensitive hepatitis B surface antigen assay.Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.Evaluation of the Procleix Ultrio Elite Assay and the Panther-System for Individual NAT Screening of Blood, Hematopoietic Stem Cell, Tissue and Organ Donors.Detection and identification of occult HBV in blood donors in Taiwan using a commercial, multiplex, multi-dye nucleic acid amplification technology screening test.Evaluation of two, commercial, multi-dye, nucleic acid amplification technology tests, for HBV/HCV/HIV-1/HIV-2 and B19V/HAV, for screening blood and plasma for further manufacture.Preanalytical stability of HIV-1 and HCV RNA: impact of storage and plasma separation from cells on blood donation testing by NAT.Occult hepatitis B virus infection in Thai blood donors.
P2860
Q27686923-AF98597B-8DAA-4395-92F2-FE218BB57950Q28069741-C1F7E776-261A-43DA-854E-6A3F7A47A1E5Q33455459-533D79FF-9FBF-4346-8654-E5D2ACFDC828Q33801311-5AECFEB0-DD8F-40DD-937B-5FCECCAD61D2Q36766479-724DF6EA-8217-460E-ACAE-E28021D775A1Q37470263-CC6C5EC8-055A-43B2-8864-7BA9FA9999B2Q40404341-75DF506F-75FB-46B6-AB09-375B90916BF6Q40613598-39127FB2-5E27-4EA3-BCDB-C520BE3B63EEQ40656078-9146ED4E-29D2-4397-9042-E9CA7B0CAC23Q42279560-B3F539E0-408B-4E44-88CD-77A0370AA5C9Q42987407-994BF92F-A18D-4DE2-8AA1-053D7AE9A53CQ43001633-6CB52E0A-F48B-4ACF-88C7-54DA1CA75FAAQ45369715-1C20EC2F-11E9-433B-B079-AB653A48B646
P2860
Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Identification of low HBV-DNA ...... on test (NAT) in blood donors.
@en
Identification of low HBV-DNA levels by nucleic acid amplification test
@nl
type
label
Identification of low HBV-DNA ...... on test (NAT) in blood donors.
@en
Identification of low HBV-DNA levels by nucleic acid amplification test
@nl
prefLabel
Identification of low HBV-DNA ...... on test (NAT) in blood donors.
@en
Identification of low HBV-DNA levels by nucleic acid amplification test
@nl
P2093
P50
P1433
P1476
Identification of low HBV-DNA ...... on test (NAT) in blood donors.
@en
P2093
Angela Candido
Domenico Genovese
Michelina Miceli
Paola Chionne
Paola Iudicone
Stefano Dettori
P304
P356
10.1016/J.JINF.2009.06.007
P577
2009-06-18T00:00:00Z